International Conference on Biotechnology and Healthcare December 07-08, 2020 Auckland, Newzealand

Track 1: Modern Biotechnology

In modern biotechnology, researchers transform DNA and proteins to shape the capabilities of living cells, plants, and animals into somewhat useful for humans. Biotechnologists do this by sequencing, or reading, the DNA found in nature, and then operating it in a test tube – or, more recently, inside of living cells. The most exciting biotechnology developments of recent times are occurring at the microscopic level within the membranes of cells. After years of basic research into decoding the chemical and genetic makeup of cells, biologists their work has brought us the powerful cellular tools at biotechnologists disposal today. In the coming decades, scientists will use the tools of biotechnology to function cells with increasing control, from precision editing of DNA to synthesizing entire genomes from their basic chemical building blocks.  And biotechnology may be significantly fight against climate change.

Track 2: Role of Biotechnology to Detect Infectious Disease

Infectious diseases pose a threat to humans because they can pass quickly from person to person and affect a large number of people in a very short time. Influenza, or "the flu," is an infectious disease. You may have heard about avian and swine flus in the news. With the growing fear of bioterrorism and a pandemic flu, scientists are using biotechnology to develop new diagnostic tools for rapid and sensitive detection of pathogens. Biotechnology is used extensively in the study of emerging infectious diseases.

Track 3: Molecular diagnosis

Molecular diagnostics is a collection of techniques used to study biological markers in the genome and proteome the individual's genetic code and how their cells express their genes as proteins by applying molecular biology to medical testing. The method is used to diagnose and monitor disease, notice risk, and decide which therapies will work best for individual patients. These tests are useful in a range of medical specialisms, including infectious disease, oncology, human leucocyte antigen typing, coagulation and pharmacogenomics the genetic prediction of which drugs will work best.

Track 4: Vaccines for disease prevention

Vaccination, the administration of an antigenic material (vaccine), is considered to be the most effective method for disease prevention and control. A vaccine usually contains an agent that resembles a diseases‐causing pathogen and is often made from inactivated microbes, live attenuated microbes, its toxins, or part of surface antigens (subunit). However, the modern biotechnological tools and genomics have opened a new era to develop novel vaccines and many products are successfully marketing around the world. It is important to formulate and deliver these vaccines appropriately to maximize the potential advances in prevention, therapy, and vaccinology. New vaccines employing biotechnological innovations are helping us to change the way for illness prevention. The clinical application of vaccines will be diversified along with the development of biotechnologies. In modern society, the outbreak of many infectious diseases has decreased through vaccination, but the burden of non-infectious diseases is growing. The new biotechnologies may result in not only the appreciation of vaccines which are critical in inducing protection against an infectious disease but also the production of therapeutic vaccines which are effective for all diseases including infectious and non-infectious diseases.

Track 5:- Biotechnology to Detect Inherited Disease

Inherited genes that reside in chromosomes and determine how proteins are formed in the body may be faulty or otherwise damaged. Genes code for the production of proteins in all living things. Changes that occur naturally in our genes are called mutations. While mutations are responsible for the genetic variation that makes living things different from one another, some mutations may produce defective proteins that cause disease. The tools and techniques researchers use to hunt down disease-causing genes change with a deepening understanding of genomes and with integration of new technologies.

Track 6:- Cancer Biotechnology

Many forms of chronic disease such as cancer and cardiovascular disfunction can, in part, be attributed to diet and arising from the awareness of the relationship between diet and disease has evolved the concept of functional foods. Cancer is caused by undesired changes in the genome as well as in the proteome. These changes allow cancer cells to evade normal cellular control mechanisms and so these cells start growing uncontrolled. Molecular research has showed major types of mutations for many cancer types, locating specific targets and drug development.

Track 7:- Gene and Cellular Therapies

Gene therapy comprises the transmission of genetic material, typically in a carrier or vector, and the approval of the gene into the suitable cells of the body. Cell therapy contains the transmission of cells with the applicable function of the patient. Gene and cell therapy is the use of genes and cells to treat disease. A gene is the unit of DNA that contains hereditary information that is passed down from generation to generation. All genes together are called the genome. Genes may contain information about visible traits, such as height or eye colour. Many genes contain the instructions for RNA or protein molecules that are not visible from the outside but perform important functions in the body's cells. Cells are the building blocks of plants and animals. They are small functional units that work together to form organs and tissues.

Track 8:- Tissue Engineering

New advances in stem-cell technology have well the prognosis for tissue engineering. The usage of cultured stem and/or progenitor cells has the potential to advance the amount of renewal, and also increases the likelihood that the transplanted tissue will join with the surrounding tissue. It could ultimately even reduce or eliminate the need for immunosuppressive drugs. The term regenerative medicine is often used synonymously with tissue engineering, although those involved in regenerative medicine place more emphasis on the use of stem cells or progenitor cells to produce tissues.

Track 9:- Nano Biotechnology

Nano biotechnology which is knowingly concerned with the creation and application of various nanomaterials specific to pharmacy and medicine has huge potential to solve life-threatening issues of important human diseases. Mostly in recent years, large amount of novel nanotherapeutics and nanodevices have been extensively explored with huge positive influences on human health, comprise nanoparticles for the delivery of small molecule drugs, proteins, DNAs, RNAs and MRNAs for dissimilar kinds of therapy via dissimilar administration pathways, brand-new nanomaterials for novel treatment approaches and multi-functionalized nano-agents for imaging as well as the development of novel nanotechnology-based diagnosis/detection approaches.

BIOTECH CONGRESS 2020 welcomes attendees, presenters, and exhibitors from all over the world to Auckland, Newzealand. We are delighted to invite you all to attend and register for the “International Conference on Biotechnology and Healthcare” which is going to be held during December 02-03, 2020 Auckland, Newzealand. The Organizing Committee is gearing up for an thrilling and informative conference program with plenary talks, symposia, workshops on a variety of topics, poster presentations and many programs for members from all over the world. We invite you to join us at the BIOTECH CONGRESS 2020, where you will be sure to have a meaningful experience with scholars from around the world. All the members of BIOTECH CONGRESS 2020 Organizing Committee will look forward to meet you at Auckland, Newzealand.

The Global Biopharmaceutical Market is poised to grow at a CAGR of around 10.1% over the next decade to reach approximately $459.81 billion by 2025.The opportunity in biopharmaceuticals is big and growing too rapidly to ignore. Today biopharmaceuticals generate global revenues of $163 billion, making up about 20%of the Pharma market. It’s by far the fastest-growing part of the industry. Biopharma and Technology current annual growth rate of more than 8% is double that of conventional Pharma, and growth is expected to continue at that rate for the foreseeable future.

It is estimated at USD 215 million for the year 2017 and is projected to reach USD 269 billion by the year 2021. The estimated CAGR during the forecast period (2017-2021) is 5.76%. The pharmaceutical market in Asia is set to rise from around $70 billion in 2016 to $72 billion by 2021, representing a low compound annual growth rate of 0.3%, according to Global Data, a recognized leader in providing business information and analytics. The penetration of generics has grown robustly over the past few years. The government has also made a target towards achieving a generic penetration of 60% by 2018. This is expected to create huge opportunities for both domestic and foreign generic manufacturers in World.

The biggest change for Pharma in Asia was the 2014 revision of the nation’s keystone pharmaceuticals law, renamed the PMD Act-for pharmaceutical and medical devices. Japanese officials proudly say some drug approvals in Japan are now faster than in both Europe and the U.S.

 The Glo